Group One Trading
EPRS

Group One Trading’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Group One Trading’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,157
Closed -$41K – 5559
2015
Q4 		$41K Buy
13,157
+8,832
+204% +$39.8K ﹤0.01% 3535
2015
Q3 		$19K Buy
+4,325
New +$25.4K ﹤0.01% 4074
2014
Q4 		– Sell
-295
Closed -$2K – 5891
2014
Q3 		$2K Buy
+295
New +$2.55K ﹤0.01% 4989

Other funds holding EPRS

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Group One Trading's EPRS Position: Q1 2016 in Review

Group One Trading sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q1 2016, closing a stake of 13,157 shares — an estimated $41K sold.

Group One Trading first reported a position in EPRS in Q3 2014 and held it in 3 quarters. The position peaked at $41K in Q4 2015. 37 funds tracked by Wall St. Rank hold EPRS as of Q1 2016.

  • Group One Trading reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • Group One Trading sold 13,157 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q1 2016, an estimated $41K.
  • Group One Trading first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 3 quarters.
  • Group One Trading's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $41K in Q4 2015.
  • 37 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q1 2016.

Based on Group One Trading's 13F filing for Q1 2016, filed 12 May 2016.